Q1 2022 Gelesis Holdings Inc Earnings Call Transcript
Good afternoon, everyone, and thank you for participating in today's conference call to discuss Gelesis' financial results for the fiscal quarter ended March 31, 2022.
Joining us today are Yishai Zohar, Founder and CEO of Gelesis; and Elliot Maltz, CFO of Gelesis. There'll be discussion of fiscal 2022 1st quarter and launch update in the company's commercial product, Plenity.
Plenity is indicated to aid in weight management in adults with excess weight or obesity with body mass index of 25 to 40 kilograms per square meter when used in conjunction with diet and exercise. For important safety information about Plenity, please see our website at myplenity.com or call 1-844-PLENITY. Following their remarks, we'll open the call to your questions.
Before we begin today, I want to remind everyone that this conference call may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including statements relating to Gelesis' estimates of its future business outlook, prospects or financial results, including projected sales and EBITDA.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |